The Cancer Specific Ubiquitin Ligase MAGE-A3/6-TRIM28 Drives Tumorigenesis by Ubiquitination and Proteasomal Degradation of AMPK
dc.contributor.advisor | Yu, Hongtao | en |
dc.contributor.committeeMember | Levine, Beth | en |
dc.contributor.committeeMember | White, Michael A. | en |
dc.contributor.committeeMember | Potts, Patrick Ryan | en |
dc.creator | Pineda, Carlos Tyler | en |
dc.date.accessioned | 2018-01-04T21:09:36Z | |
dc.date.available | 2018-01-04T21:09:36Z | |
dc.date.created | 2015-12 | |
dc.date.issued | 2015-08-27 | |
dc.date.submitted | December 2015 | |
dc.date.updated | 2018-01-04T21:03:35Z | |
dc.description.abstract | The genes MAGE-A3 and MAGE-A6 (MAGE-A3/6) have a unique expression pattern in which they are normally expressed in the adult testis but are aberrantly expressed in cancer. It is known that when expressed in cancer, MAGE-A3/6 is a negative prognostic indicator and cancer cells are dependent on it for survival. Using the knowledge that MAGE-A3/6 binds and regulates the E3 ubiquitin ligase TRIM28, I investigated its biochemical role in cancer. I used unbiased methods to identify 19 novel substrates of MAGE-A3/6-TRIM28, including the known tumor suppressor AMPK. Ubiquitination of AMPK by MAGE-A3/6-TRIM28 induces its proteasomal degradation, thereby enhancing mTOR signaling and inhibiting autophagy within cells. Through this modulation of AMPK, MAGE-A3/6 is also able to act as an oncogene, inducing anchorage independent growth and the growth of tumors in vivo. Understanding the mechanism by which MAGE-A3/6 acts as an oncogene has revealed potential avenues of therapeutic intervention. Treatment of MAGE-A3/6 expressing cells with AMPK agonists reverses oncogenic properties in vitro. Ultimately, these studies have revealed how a germline protein functions in cancer and the potential points for therapeutic intervention. | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.oclc | 1017760194 | |
dc.identifier.uri | https://hdl.handle.net/2152.5/4447 | |
dc.language.iso | en | en |
dc.subject | AMP-Activated Protein Kinases | en |
dc.subject | Antigens, Neoplasm | en |
dc.subject | Neoplasm Proteins | en |
dc.subject | Neoplasms | en |
dc.subject | Ubiquitination | en |
dc.subject | Ubiquitin-Protein Ligases | en |
dc.title | The Cancer Specific Ubiquitin Ligase MAGE-A3/6-TRIM28 Drives Tumorigenesis by Ubiquitination and Proteasomal Degradation of AMPK | en |
dc.type | Thesis | en |
dc.type.material | text | en |
thesis.degree.department | Graduate School of Biomedical Sciences | en |
thesis.degree.discipline | Cell Regulation | en |
thesis.degree.grantor | UT Southwestern Medical Center | en |
thesis.degree.level | Doctoral | en |
thesis.degree.name | Doctor of Philosophy | en |